Value DossierMarket Access
The same evidence, rebuilt from scratch for every market.
Every market wants the value story in its own format, and each rebuild starts from the same evidence in a different shape. The dossier arrives authored from one evidence base, in the format each payer and HTA body expects, every claim sourced.
What it does.
Payer value dossiers.
AMCP-format dossiers authored from your clinical and economic evidence, every claim sourced.
HTA submissions per market.
Built to each body's template and evidence requirements from the same underlying dossier.
Economic models and summaries.
Budget impact narratives, HEOR evidence summaries and pricing and reimbursement dossiers, drawn from the same source.
Objections answered from precedent.
A payer objection arrives answered from your approved evidence and from every answer your team has already given, tender and RFP responses included.
The rest of market access.
Start where it hurts.
We'll run it live on a section of your own work.
Request a demoYour data stays in your environment. Customer data never trains foundation models.